Dr. Erin Huan Lin, DO

Dr. Lin practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Lin's NPI, 1780983411, was assigned on March 21, 2011. Dr. Lin graduated from WesternU College of Osteopathic Medicine of the Pacific in 2009. Dr. Lin holds California license 20A11452.

Dr. Lin's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Lin's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices. Vendor and product names are available with a free account.

Surgery is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Lin is board certified in surgery by the AOA Board of Surgery. Dr. Lin is licensed in California.

Dmand AI lists breast reconstruction and mastectomy among the conditions Dr. Lin treats.

CMS data shows 273 Medicare services from Dr. Lin across 11 procedure codes in 2024, for 184 Medicare patients. Medicare paid $32,097 for them.

CMS counts 184 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high cholesterol, and 71% have cancer. 36% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 55, with 94% women.

In 2024, Dr. Lin wrote 15 Medicare Part D claims. 93% of them were for generic drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth. CMS counts 35 procedures of mastectomy by Dr. Lin, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Lin, published from 2015 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Breast Neoplasms. Dr. Lin has published most often in Case Rep Oncol. Dr. Lin's most frequent co-authors are Ritesh Parajuli, MD, Alice Marie Police, MD and Stephanie R. Akbari, MD.

Dmand AI links Dr. Lin to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Carcinoma In Situ, Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 15 general payments to Dr. Lin from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Carl Zeiss Meditec, Inc. paid the most, $440.

Dr. Lin graduated from WesternU College of Osteopathic Medicine of the Pacific in 2009. Dr. Lin is a member of AOA.

Dr. Lin is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.